Rhythm Control Better Prevents Stroke than Rate Control in Patients with Concomitant Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Nationwide Population Based Cohort Study with Long-Term Follow-Up.
In patients with AF and HCM, rhythm control with mainly pharmacological treatment better prevented stroke than rate control in long-term follow-up. The beneficial effect of lowering stroke risk through rhythm control was independent of oral anticoagulant use.
Authors
- Yu-Shan Chien
- Shang‐Ju Wu (ORCID: https://orcid.org/0000-0002-0772-869X)
- Yu‐Yu Hsiao (ORCID: https://orcid.org/0000-0001-9296-4517)
- Guan‐Yi Li (ORCID: https://orcid.org/0000-0002-0550-8837)
- Yu‐Cheng Hsieh (ORCID: https://orcid.org/0000-0001-6218-7139)
- Jin‐Long Huang (ORCID: https://orcid.org/0000-0001-6566-5546)
- Jiunn‐Cherng Lin
- Yun-Yu Chen (ORCID: https://orcid.org/0000-0002-5632-3445)
- Ching‐Heng Lin (ORCID: https://orcid.org/0000-0002-2450-6108)
- Yenn-Jiang Lin
- Ming-Jen Kuo
- Cheng-Hung Li (ORCID: https://orcid.org/0009-0001-1685-4655)
- Chi-Jen Weng
Institutions
- International Baccalaureate (CH)
- National Yang Ming Chiao Tung University (TW)
- Providence University (TW)
- Taipei Veterans General Hospital (TW)
- Taichung Veterans General Hospital (TW)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6515/acs.202501_41(1).20241111a
- Citations
- 3
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- National Science Council
- Taichung Veterans General Hospital